Bizarre Patents
Hands free towel carrying system
A hands free towel carrying system for coupling a towel to a user to prevent loss, theft or contamination.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20070122383 | Interleukin-10 compositions for the treatment of adenocarcinomas The present invention is directed to methods for the treatment of adenocarcinomas that are characterized by the overexpression of a particular oncogene, Pim-1. The procedure involves administering a therapeutically effective amount of interleukin-10 that has been couple... | 05/31/2007 |
| 20070122384 | Method for treating inflammatory bowel disease A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombina... | 05/31/2007 |
| 20070122385 | Replication competent viruses capable of silencing virus inhibitory factor expression Described is a replication-competent virus capable of replication and having lytic capacity in target cells. The virus comprises in the genome thereof, at least one DNA sequence coding for a silencing factor functional in reducing expression of a target gene in the targ... | 05/31/2007 |
| 20070122386 | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles The present invention provides a method for preparing a hair dermal papilla cell preparation comprising preparing a cell suspension by removing epidermal tissue from skin tissue and subjecting the resulting dermal tissue fraction to collagenase treatment, and cyropreser... | 05/31/2007 |
| 20070122387 | Hair grafts derived from plucked hair The present invention is a hair graft derived from a plucked hair comprising a plucked hair having adhered epidermal stem cells and associated follicular dermal cells. The present invention also includes methods of making a hair graft, methods of implanting a hair graft... | 05/31/2007 |
| 20070122388 | Tissue graft compositions and methods for producing same A tissue graft composition is described herein that includes a segment of small intestinal submucosa having at least one nanoparticle incorporated therein such that the permeability of the segment of small intestinal submucosa is altered, thereby providing the segment o... | 05/31/2007 |
| 20070122389 | Stage specific follicle maturation systems A three-dimensional matrix system is described herein. The system is used to surround developing tissue and support continued interaction between, for example, an oocyte and a supporting cellular structure. Oocytes grown to maturity can then be retrieved from the matrix... | 05/31/2007 |
| 20070122390 | GRAFT WITH INCREASED RESISTANCE TO ENZYMATIC DEGRADATION Described are devices, methods, and systems for grafting tissues or organs that are exposed to bacterial or mammalian enzymes that degrade collagenous materials. Illustrative medical grafts are processed by contacting a collagenous extracellular matrix (ECM) material wi... | 05/31/2007 |
| 20070122391 | Compositions and methods for non-targeted activation of endogenous genes The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those n... | 05/31/2007 |
| 20070122392 | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel Embryonic stem cells are propagated in a hyaluronic acid. ... | 05/31/2007 |
| 20070122393 | Immunophenotype and immunogenicity of human adipose derived cells The present invention encompasses methods and compositions for generating an isolated adipose tissue-derived stromal cell exhibiting a low level of immunogenicity. The present invention encompasses methods and compositions for reducing an immune response associated with... | 05/31/2007 |
| 20070122394 | Compositions and Methods for Liver Growth and Liver Protection The present invention provides pharmaceutical compositions and methods for liver proliferation and protection. Specifically useful are VEGFR modulating agents capable of promoting liver growth. Disclosed compositions and methods may be useful for promoting proliferation... | 05/31/2007 |
| 20070122395 | Genetic and pharmacological regulation of antidepressant-sensitive biogenic amine transporters through PKG/p38 map kinase The invention relates to the observation that the p38 mitogen-activated protein kinase pathway is an important regulator of biogenic amine transporter (BAT) function. By using modulator of p38 MAPK, one can alter BAT function in a specific manner. This recognition of th... | 05/31/2007 |
| 20070122396 | Morphogenic proteins and stimulatory factors in gene therapy Gene therapy methods for tissue formation, repair and regeneration using nucleic acids encoding morphogenic proteins and morphogenic protein stimulatory factors (MPSFs) are provided. ... | 05/31/2007 |
| 20070122397 | Probiotic storage and delivery Probiotic microorganisms are micro encapsulated by dispersing the probiotic microorganism in an aqueous suspension of a film forming protein and a carbohydrate; in an oil in water emulsion of a film forming protein and a carbohydrate and a fat; or in an oil which is sub... | 05/31/2007 |
| 20070122398 | Encapsulated hydrophilic compounds The present invention relates to capsules for encapsulating functional agents, such as flavors, fragrances, pharmaceuticals, vitamins, etc. The capsules are suitable for the encapsulation of hydrophobic as well as hydrophilic substances. The capsules include a micro-org... | 05/31/2007 |
| 20070122399 | Composition and method for facilitating bone healing The present invention provides a nutritional composition effective in facilitating bone healing in human, comprising lysine, proline, ascorbic acid, copper, vitamin B6. The nutritional composition contains 27-34% wt lysine, 14-16% wt proline, and 42-47% wt as... | 05/31/2007 |
| 20070122400 | Composition having liver function protecting effect The present invention provides a highly safe composition which is effective for protecting liver functions and preventing liver dysfunctions in the case where liver dysfunctions rise by various causes. The present inventors found that oxidized coenzyme Q is effective fo... | 05/31/2007 |
| 20070122401 | Methods and compositions for modulating telomerase reverse transcriptase (tert) expression Nucleic acid compositions comprising an Ikaros or WT1 repressor binding site that act to repress transcription of the telomerase reverse transcriptase (TERT) coding sequence, as well as vectors and constructs including the same, are provided. Also provided are methods o... | 05/31/2007 |
| 20070122402 | Immunoglobulin preparations having increased stability The present invention relates to a protein preparation having increased stability, comprising a stabiliser selected from the group consisting of non-polar and basic amino acids and having a pH of 4.0 to 5.2. The invention further relates to a pharmaceutical composition ... | 05/31/2007 |
| 20070122403 | Molecules with extended half-lives, compositions and uses thereof The present invention provides molecules, including IgGs, non-IgG immunoglobulins, proteins and non-protein agents, that have increased in vivo half-lives due to the presence of an IgG constant domain, or a portion thereof that binds the FcRn, having one or more amino a... | 05/31/2007 |
| 20070122404 | Humanized immunoglobulin reactive with alpha4beta7 integrin The present invention relates to a humanized immunoglobulin that has binding specificity for α4β7 integrin and comprises the complementarity determining regions (CDRs) of mouse Act-1 antibody, and to the humanized light chain of the humanized immunoglobulin. The prese... | 05/31/2007 |
| 20070122405 | Human G-protein chemokine receptor (CCR5) HDGNR10 The present invention relates to a human protein called Human G-protein Chemokine Receptor (CCR5) HDGNR10, and isolated polynucleotides encoding this protein. The invention is also directed to human antibodies that bind Human G-protein Chemokine Receptor (CCR5) HDGNR10 ... | 05/31/2007 |
| 20070122406 | Optimized proteins that target Ep-CAM Humanized Ep-CAM-targeting antibodies and methods of making and using the same are provided. ... | 05/31/2007 |
| 20070122407 | ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES Antibodies are disclosed which bind to ErbB3 protein and further possess any one or more of the following properties: an ability to reduce heregulin-induced formation of an ErbB2-ErbB3 protein complex in a cell which expresses ErbB2 and ErbB3; the ability to increase th... | 05/31/2007 |
| 20070122408 | Fc Labeling for Immunostaining and Immunotargeting The present invention discloses methods of labeling Fc portions of antibodies, or fusion proteins incorporating Fc portions of antibodies, so that they can be used in immunostaining or immunolabeling procedures. A wide variety of labels can be used. A linker can be used... | 05/31/2007 |
| 20070122409 | Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors Immunomodulating agents comprising at least one Fc receptor ligand and at least one immunosuppressive factor are provided as are methods for their manufacture and use. The immunomodulating agents may be in the form of polypeptides or chimeric antibodies and preferably i... | 05/31/2007 |
| 20070122410 | Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL The invention relates to the use of a superagonistic monoclonal antibody (mAb), which is specific for a naturally costimulatory receptor expressed on T cells, or a mimicry compound thereto, for producing a pharmaceutical composition for the treatment of diseases occurri... | 05/31/2007 |
| 20070122411 | Solid forms of anti-egfr antibodies The invention relates to solid forms of antibodies against the EGF receptor, in particular precipitates and crystals of monoclonal antibodies against the EGF receptor, particularly preferably of Mab C225 (cetuximab) and Mab h425 (EMD 72000), which result in biologically... | 05/31/2007 |
| 20070122412 | EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE The present invention is directed to novel polypeptides designated herein as EG-VEGF and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules compri... | 05/31/2007 |
| 20070122413 | IL-21 ANTAGONISTS Monoclonal antibodies are identified that bind the IL-21 protein. These antibodies are used to identify regions of the IL-21 protein to where binding neutralizes IL-21 activity. Hybridomas and methods of producing anti-IL-21 monoclonal antibodies are described. The mono... | 05/31/2007 |
| 20070122414 | Surface marker-directed cancer therapeutics Disclosed are methods for treating and/or preventing neoplasms in a patient by contacting the neoplasm with therapeutic agents capable of binding, hybridizing, or interacting with proteins on the cell surface of neoplastic cells. In addition, therapeutic compositions ar... | 05/31/2007 |
| 20070122415 | Compound and method for suppressing retroviral replication In one aspect, the invention provides an antiretroviral peptide that suppresses replication of a retrovirus and the use thereof to inhibit retroviral replication within cells infected with a retrovirus. The method can be used in vivo to treat retroviral infection in hum... | 05/31/2007 |
| 20070122416 | CROSS-REACTIVE DISPLACING ANTIBODIES FROM COLLAGEN-BINDING PROTEINS AND METHOD OF IDENTIFICATION AND USE Antibodies to the CNA protein and to other regions from the collagen binding domain, including domain CNA19, are provided, and antibodies produced in this manner have been shown to be cross reactive to both Staphylococcus aureus and Staphylococcus epidermidis ... | 05/31/2007 |
| 20070122417 | Immunotherapy method The present invention relates to the use of immunomodifying agents to effect change in the T helper-type 1 (TH1) or T helper-type 2 (TH2) arms of the immune response and thereby treat TH1 or TH2 mediated diseases. In particular, the present invention relates to a method... | 05/31/2007 |
| 20070122418 | COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS Therapeutic dried compositions are described. The composition is in solid dose form and includes a polyol and an immunogenic agent. ... | 05/31/2007 |
| 20070122419 | Methods and compositions for treating atherosclerosis During the progression of atherosclerosis, autoantibodies are induced to epitopes of oxidized low-density lipoprotein (OxLDL), and active immunization of hypercholesterolemic mice with OxLDL ameliorates athero-genesis. The present studies have identified anti-OXLDL auto... | 05/31/2007 |
| 20070122420 | Protein antigens useful for cancer therapy and vaccination PstS1 protein or fragments thereof are highly immunogenic protein antigens for vaccination and immunotherapy of cancer in humans and animals. A wild-type or a recombinant mycobacterial PstS1 protein are used for the preparation of a vaccine or therapeutical composition ... | 05/31/2007 |
| 20070122421 | Innate immune system-directed vaccines The present invention provides novel vaccines, methods for the production of such vaccines and methods of using such vaccines. The novel vaccines of the present invention combine both of the signals necessary to activate native T-cells—a specific antigen and the co-st... | 05/31/2007 |
| 20070122422 | Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids Novel sodium-independent small neutral amino acid transporters which transport L- and D-amino acids. A protein comprising the amino acid sequence represented by SEQ ID NO:1 or 4 or an amino acid derived therefrom by deletion, substitution or addition of one or more amin... | 05/31/2007 |
